2-(1-Phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid ethyl ester
≥98%
- Product Code: 108125
CAS:
1598426-03-9
| Molecular Weight: | 283.33 g./mol | Molecular Formula: | C₁₆H₁₇N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28347705 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It serves as a building block for developing potential therapeutic agents, particularly in the design of inhibitors targeting specific enzymes or receptors. Its structure is often leveraged in the creation of compounds with potential antiviral, anticancer, or anti-inflammatory properties. Researchers also explore its use in optimizing drug-like properties, such as bioavailability and metabolic stability, during the drug discovery process. Additionally, it may be employed in academic and industrial research to study structure-activity relationships (SAR) for novel drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £305.33 |
+
-
|
| 0.050 | 10-20 days | £1,323.09 |
+
-
|
| 0.250 | 10-20 days | £3,256.85 |
+
-
|
2-(1-Phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid ethyl ester
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It serves as a building block for developing potential therapeutic agents, particularly in the design of inhibitors targeting specific enzymes or receptors. Its structure is often leveraged in the creation of compounds with potential antiviral, anticancer, or anti-inflammatory properties. Researchers also explore its use in optimizing drug-like properties, such as bioavailability and metabolic stability, during the drug discovery process. Additionally, it may be employed in academic and industrial research to study structure-activity relationships (SAR) for novel drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :